Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: Possible association with susceptibility to the disease

Leukemia Research

Volumn 34, Issue 1, 2010, Pages 55-58

  Zhang, Yan ^a   Wang, Bo ^b   Ye, Shihui ^a   Liu, Sheng ^a   Liu, Mengli ^a   Shen, Chunmei ^a   Teng, Yan ^c   Qi, Jun ^a  

^a Shaan'Xi Blood Center   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Genotyping; Immunoglobulin like receptors; Leukemia; Logistic analysis; NK cells

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL4; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DP1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS4; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DP1; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER SUSCEPTIBILITY; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; NONLYMPHATIC LEUKEMIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKEMIA; POLYMORPHISM, GENETIC; RECEPTORS, KIR;

EID: 73249140403     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.04.022     Document Type: Article

References (31)

1. Li L., and Fan-yi M. Advances in environment risk factor on adult leukemia. J Environ Occup Med 23 (2006) 349-351
2. Diefenbach A., and Raulet D.H. The innate immune response to tumors and its role in the induction of T-cell immunity. Immunology 188 (2002) 9-21
3. Dupont B., and Hsu K.C. Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in haematopoietic stem cell transplantation. Curr Opin Immunol 16 (2004) 634-643
4. Lanier L.L. NK cell recognition. Immunology 23 (2005) 225-274
5. McQueen K.L., and Parham P. Variable receptors controlling activation and inhibition of NK cells. Curr Opin Immunol 14 (2002) 615-621
6. Wilson M.J., Torkar M., Haude A., et al. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc Natl Acad Sci USA 97 (2000) 4778-4783
7. Trowsdale J. Genetic and functional relationships between MHC and NK receptor genes. Immunity 15 (2001) 363-374
8. Kim H.J., Choi Y., Min W.S., et al. The activating killer cell immunoglobulin-like receptors as important determinants of acute graft-versus host disease in hematopoietic stem cell transplantation for acute myelogenous leukemia. Transplantation 84 (2007) 1082-1091
9. Leung W., Handgretinger R., Iyengar R., et al. Inhibitory KIR-HLA receptor-ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumor and lymphoma. Br J Cancer 97 (2007) 539-542
10. Hsu K.C., Gooley T., Malkki M., et al. KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy. International Histocompatibility Working Group. Biol Blood Marrow Transplant 12 (2006) 828-836
11. Van der Slik A.R., and Koeleman B.P. KIR in Type I diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. J Diabetes 52 (2003) 2639-2642
12. Momot T., Koch S., Hunzelmann N., et al. Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum 50 (2004) 1561-1565
13. Yen J.H., Moore B.E., Nakajima T., et al. Major histocompatibility complex class I recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med 193 (2001) 1159-1167
14. Chen A.M., Guo X.M., Yan W.Y., et al. Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia. J Exp Hematol 15 (2007) 35-38
15. He L.X., Chen A.M., Guo X.M., et al. Association of killer cell immunoglobulin-like receptor gene with chronic myelogenous leukemia. Chin J Birth Hered 15 (2007) 33-34
16. Steffens U., Vyas Y., Dupont B., et al. Nucleotide and amino acid sequence alignment for human killer cell inhibitory receptors (KIR). Tissue Antigens 51 (1998) 398-413
17. Biron C.A., and Brossay L. NK cells and NKTcells in innate defense against viral infections. Curr Opin Immunol 13 (2001) 458-464
18. Diefenbach A., and Raulet D.H. The innate immune response to tumors and its role in the induction of T-cell immunity. Immunol Rev 188 (2002) 9-21
19. Martin M.P., Gao X., Lee J.H., et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 31 (2002) 429-434
20. Khakoo S.I., Thio C.L., Martin M.P., et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305 (2004) 872-874
21. Nelson G.W., Martin M.P., Gladman D., et al. Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol 173 (2004) 4273-4276
22. Nikitina-Zake L., Rajalingam R., Rumba I., and Sanjeevi C.B. Killer cell immunoglobulin-like receptor genes in Latvian patients with type 1 diabetes mellitus and healthy controls. Ann NY Acad Sci 1037 (2004) 161-169
23. Carrington M., Wang S., Martin M.P., et al. Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J Exp Med 201 (2005) 1069-1075
24. Naumova E., Mihaylova A., Stoitchkov K., et al. Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals. Cancer Immunol Immunother 54 (2005) 172-178
25. Hsu K.C., Liu X.R., Selvakumar A., et al. Killer Ig-like receptor(KIR) haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol 169 (2002) 5118-5129
26. Yen J.H., Moore B.E., Nakajima T., et al. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med 193 (2001) 1159-1167
27. Suzuki Y., Hamamoto Y., Ogasawara Y., et al. Genetic polymorphisms of killer cell immunoglobulin-like receptors are associated with susceptibility to psoriasis vulgarism. J Invest Dermatol 122 (2004) 1133-1136
28. Hou Y.F., Zhang Y.C., Jiao Y.L., et al. The association of KIR gene polymorphism and systemic lupus erythematosus. J Microbiol Immunol 27 (2007) 463-467
29. Jiao Y.L., Ma C.Y., Wang L.C., et al. Polymorphisms of KIRs gene and HLA-C alleles in patients with ankylosing spondylitis: possible association with susceptibility to the disease. J Clin Immunol 28 (2008) 343-349
30. Kim H.J., Choi Y., Min W.S., et al. The activating killer cell immunoglobulin-like receptors as important determinants of acute graft-versus host disease in hematopoietic stem cell transplantation for acute myelogenous leukemia. Transplantation 84 9 (2007) 1082-1091
31. VandenBussche C.J., Mulrooney T.J., Frazier W.R., et al. Dramatically reduced surface expression of NK cell receptor KIR2DS3 is attributed to multiple residues throughout the molecule. Genes Immun 10 2 (2009) 162-173 [Epub 2008 November 13]